188 related articles for article (PubMed ID: 28841206)
1. Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish.
Lu JW; Hsieh MS; Hou HA; Chen CY; Tien HF; Lin LI
Blood Cancer J; 2017 Aug; 7(8):e593. PubMed ID: 28841206
[TBL] [Abstract][Full Text] [Related]
2. Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia.
Hou HA; Lu JW; Lin TY; Tsai CH; Chou WC; Lin CC; Kuo YY; Liu CY; Tseng MH; Chiang YC; Peng YL; Tang JL; Gong Z; Lin LI; Tien HF
Blood Cancer J; 2017 Jul; 7(7):e588. PubMed ID: 28753595
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Transcription Factor SOX4 in Acute Myeloid Leukemia and Its Clinical Significance].
Zhao JL; Zhang ZH; Wang R; Yuan HL; Chen G; Zhang J; Muhashi ML; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):20-24. PubMed ID: 30738442
[TBL] [Abstract][Full Text] [Related]
4. Sox4 regulates choroid fissure closure by limiting Hedgehog signaling during ocular morphogenesis.
Wen W; Pillai-Kastoori L; Wilson SG; Morris AC
Dev Biol; 2015 Mar; 399(1):139-153. PubMed ID: 25557621
[TBL] [Abstract][Full Text] [Related]
5. Sox4 cooperates with CREB in myeloid transformation.
Sandoval S; Kraus C; Cho EC; Cho M; Bies J; Manara E; Accordi B; Landaw EM; Wolff L; Pigazzi M; Sakamoto KM
Blood; 2012 Jul; 120(1):155-65. PubMed ID: 22627767
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
[TBL] [Abstract][Full Text] [Related]
7. Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.
Zhang H; Alberich-Jorda M; Amabile G; Yang H; Staber PB; Di Ruscio A; Welner RS; Ebralidze A; Zhang J; Levantini E; Lefebvre V; Valk PJ; Delwel R; Hoogenkamp M; Nerlov C; Cammenga J; Saez B; Scadden DT; Bonifer C; Ye M; Tenen DG
Cancer Cell; 2013 Nov; 24(5):575-88. PubMed ID: 24183681
[TBL] [Abstract][Full Text] [Related]
8. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
10. FAM213A is linked to prognostic significance in acute myeloid leukemia through regulation of oxidative stress and myelopoiesis.
Oh CK; Ha M; Han ME; Heo HJ; Myung K; Lee Y; Oh SO; Kim YH
Hematol Oncol; 2020 Aug; 38(3):381-389. PubMed ID: 32124993
[TBL] [Abstract][Full Text] [Related]
11. MYCN transgenic zebrafish model with the characterization of acute myeloid leukemia and altered hematopoiesis.
Shen LJ; Chen FY; Zhang Y; Cao LF; Kuang Y; Zhong M; Wang T; Zhong H
PLoS One; 2013; 8(3):e59070. PubMed ID: 23554972
[TBL] [Abstract][Full Text] [Related]
12. RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study.
Shen L; Zhu J; Chen F; Lin W; Cai J; Zhong J; Zhong H
BMC Cancer; 2015 Dec; 15():970. PubMed ID: 26674644
[TBL] [Abstract][Full Text] [Related]
13. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
14. PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice.
Omidvar N; Maunakea ML; Jones L; Sevcikova S; Yin B; Himmel KL; Tennant TR; Le Beau MM; Largaespada DA; Kogan SC
Haematologica; 2013 Mar; 98(3):424-7. PubMed ID: 23144197
[TBL] [Abstract][Full Text] [Related]
15. The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia.
Fernando TR; Contreras JR; Zampini M; Rodriguez-Malave NI; Alberti MO; Anguiano J; Tran TM; Palanichamy JK; Gajeton J; Ung NM; Aros CJ; Waters EV; Casero D; Basso G; Pigazzi M; Rao DS
Mol Cancer; 2017 Jul; 16(1):126. PubMed ID: 28724437
[TBL] [Abstract][Full Text] [Related]
16.
Wang W; Li H; Huang M; Wang X; Li W; Qian X; Jing L
Open Biol; 2022 Oct; 12(10):220172. PubMed ID: 36285442
[No Abstract] [Full Text] [Related]
17. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
18. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of a myeloid-lineage specific gene lysozyme C during zebrafish myelopoiesis.
Kitaguchi T; Kawakami K; Kawahara A
Mech Dev; 2009; 126(5-6):314-23. PubMed ID: 19275935
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑339‑5p inhibits cell proliferation of acute myeloid leukaemia by directly targeting SOX4.
Sun X; Liu H; Li T; Qin L
Mol Med Rep; 2018 Dec; 18(6):5261-5269. PubMed ID: 30320397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
